Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

NCT00227110 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Nonalcoholic Steatohepatitis

Interventions

DRUG: Pioglitazone
DRUG: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]
[object Object]